JPRN-UMIN000030661已完成未知
The study for usefulness of switching nucleoside/nucleotide analogues (NAs) to tenofovir alafenamide fumarate in patients with chronic HBV infection treated with other NAs - TAF for chronic HBV infection
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients who is taking immunosuppressive agents (2) Patients who is infected also with HIV (3) Patients treated with contraindicated drug together with TAF. (4) Patients who is considered inappropriate for this study by doctors in attendance
研究者
相似试验
招募中
不适用
Effect of switching therapy from nucleos(t)ide analogue to pegylated-interferon in patients with chronic hepatitis Bchronic hepatitis BJPRN-UMIN000012415Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine200
尚未招募
4 期
A pilot study of switching from multipe nucleos(t)ide analogues to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatits B virus infectioD019694chronic hepatits BHBVJPRN-jRCT1031220145MOCHIDA Satoshi20
进行中（未招募）
不适用
Efficacy and pharmacokinetics of a switch from a regimen consisting of emtricitabine, nevirapine and tenofovir to rilpivirine, emtricitabine and tenofovir in virologically suppressed HIV-1 infected patients.EUCTR2012-001142-18-NLErasmus MC50
进行中（未招募）
1 期
A pilot phase II study of a nucleoside sparing regimen of Dolutegravir + Atazanavir/r in HIV-1 infected patients with detectable viremia (Dolatav Study)EUCTR2015-001206-33-ITOSPEDALE SAN RAFFAELE40
进行中（未招募）
1 期
orwegian Nucleoside Analogue Stop Study (Nuc-STOP) - A trial in chronic hepatitis B, aiming at achieving a functional cureHBeAg negative chronic hepatitis BMedDRA version: 20.1 Level: PT Classification code 10052297 Term: Hepatitis B e antigen negative System Organ Class: 10022891 - InvestigationsEUCTR2018-000724-34-SEOslo University Hospital HF130